Since joining CHR, Chrystalla has developed her expertise in EU Generics and Biosimilars, providing clients with advice on supply chain dynamics, commercial strategy and life-cycle management. Apart from supporting numerous generics workstreams with comprehensive competitive landscaping and regulatory dynamics knowledge in the US, EU, Canada and India, Chrystalla has acquired a varied project experience by leading deep dives across several therapeutic areas, including cell therapy support solutions, eco-friendly products landscaping, and omnichannel promotional strategy. Recently, she has also applied her strong research and analysis skills to support clients with end-to-end conference coverage in the respiratory, ophthalmology, cardiovascular, and transplantation fields.
In addition to her curiosity and drive to expand her understanding in the field of competitive intelligence, she has also been extensively involved in internal initiatives, as highlighted by her contribution to CHR’s sustainability working group, driving the company’s environmental responsibility strategy and approach towards carbon neutrality and net zero operation.
Chrystalla holds a PhD in Cardiovascular Science from Imperial College London, where she worked on human heart regeneration following acute myocardial infarction using paracrine secreted factors. Prior to that, she completed an MRes in Stem Cell Biology at UCL and a BSc in Biochemistry at Imperial College London.
Outside work, Chrystalla loves to travel, swim, practice (aerial) yoga, and spend time with family and friends.